AFL
34
6
UA
48
6
STX
34
2
LEG
16
2
MRK
25
2
GRMN
53
3
MA
60
5
HUM
25
4
SWK
53
4
ADT
12
2
SLG
37
6
FOXA
67
5
LUV
45
3
IR
46
3
ORCL
49
3
DE
49
3
R
55
-2
BIIB
36
8
FMC
23
7
ZBH
69
15
AFL
34
6
UA
48
6
STX
34
2
LEG
16
2
MRK
25
2
GRMN
53
3
MA
60
5
HUM
25
4
SWK
53
4
ADT
12
2
SLG
37
6
FOXA
67
5
LUV
45
3
IR
46
3
ORCL
49
3
DE
49
3
R
55
-2
BIIB
36
8
FMC
23
7
ZBH
69
15
Financhill
Back

GSK PLC 10K Form

Sell
29

GSK
GSK PLC

Last Price:
$33.61
Seasonality Move:
4.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GSK News And Ratings

See the #1 stock for the next 7 days that we like better than GSK

GSK Financial Statistics

Sales & Book Value

Annual Sales: $37.7B
Cash Flow: $1.7B
Price / Cash Flow: 11.45
Annual Sales: $9.19
Price / Book: 3.66

Profitability

EPS (TTM): 1.53820
Net Income (TTM): $3.2B
Gross Margin: $27.1B
Return on Equity: 18.89%
Return on Assets: 4.23%

GSK PLC Earnings Forecast

Key GSK PLC Financial Ratios

  • The Gross Profit Margin over the past 29 years for GSK is 71.76%.
  • The Selling, General & Administrative Expenses for GSK have been equal to 30.95% of Gross Profit Margin.
  • The Research & Development expenses have been 20.52% of Revenue.
  • The Interest Expense is 14.71% of Operating Income.
  • The Net Earning history of GSK is 16.25% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 22 years.

GSK PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GSK
CUSIP: 37733W
Website: gsk.com

Debt

Debt-to-Equity Ratio: 1.15
Current Ratio: 0.81
Quick Ratio: 0.52

Price-to-Earnings

Trailing P/E Ratio: 11.26
Forward P/E Ratio: 8.01

GSK Technical Analysis vs Fundamental Analysis

Sell
29
GSK PLC (GSK) is a Sell

Is GSK PLC a Buy or a Sell?

  • GSK PLC stock is rated a Sell
    The current GSK PLC [GSK] share price is $33.60. The Score for GSK is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.